Tablas de Dosis › Liraglutide
GLP-1 / Metabolic
Liraglutide Guía & Tabla de Dosis
A GLP-1 receptor agonist studied for glycemic control and weight.
También conocido comoVictoza / Saxenda
Víasubcutaneous
Liraglutide — Tabla de dosis
Cada fila citada| Objetivo | Dosis | Frecuencia | Duración | Evidencia | Fuente |
|---|---|---|---|---|---|
| Obesity treatment in children aged 6 to <12 years | 3 mg | 1x/day | 56 weeks | Clinical | PMID 39258838 |
| Weight loss in adults with obesity (active comparator dose in phase 2 trial) | 3 mg | 1x/day | 52 weeks | Clinical | PMID 30122305 |
| Weight regain or insufficient weight loss after metabolic bariatric surgery | 3 mg | 1x/day | per trial | Clinical | PMID 39134066 |
| Type 2 diabetes glycemic control and weight loss (active comparator dose) | 1.2 mg | 1x/day | 30 weeks | Clinical | PMID 31539622 |
Solo para uso de investigación y educativo. No es consejo médico.
Liraglutide Preguntas
What is the typical Liraglutide dosage?
In research, Liraglutide has been studied at 3 mg 1x/day for Obesity treatment in children aged 6 to <12 years (56 weeks). See the chart above for every studied protocol, each cited.
How do you reconstitute Liraglutide?
Mix the lyophilized Liraglutide with bacteriostatic water, then use the concentration to find your draw volume. The calculator on this page does the math for you.
Is Liraglutide dosing backed by research?
Yes — every dose on this chart maps to a peer-reviewed source. Figures we cannot anchor to a study are left out. Liraglutide is a research compound for laboratory use only.